Mubadala Invests in National Resilience to Fund Abu Dhabi Biopharma Manufacturing Facility

January 10, 2023

Mubadala Investment Company PJSC has made an equity investment in National Resilience, Inc. (Resilience) and will establish a new GMP biopharma manufacturing facility in Abu Dhabi that Resilience will operate. The collaboration expands Resilience’s global biomanufacturing footprint, integrates the Abu Dhabi site into its network, and aims to strengthen regional and global biopharma supply chains.

Buyers
Mubadala Investment Company PJSC
Targets
National Resilience, Inc. (Resilience)
Industry
Biotechnology
Location
California, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.